A sound investment
If MenAfriVac is rapidly introduced throughout sub-Saharan Africa, by 2015, 150 000 lives could be saved, with over US$ 120 million of savings in medical costs for diagnosis and treatment. Yet, the full promise of the vaccine can only be attained once the vaccine is introduced throughout the meningitis belt.